Home > News > UK small caps remain higher at midday; Qonnectis up after FY results
March 28th, 2007
UK small caps remain higher at midday; Qonnectis up after FY results
Abstract:
On the downside, shares in Oxonica fell 16-1/2 to 117-1/2 after the nanotechnology group said initial results from the second data point of 30,000 km of the fuel-borne nanocatalyst Envirox track trial - being carried out in Turkey on Turkish high-sulphur diesel fuel - are currently 'inconclusive'.
Following the news, Panmure Gordon downgraded its stance to 'hold' from 'buy' and cut its target price to 115 pence from 200. The broker also lowered revenue estimates for 2007 and 2008 by 42 pct and 56 pct respectively.
Source:
hemscott.com
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
Energy
KAIST researchers introduce new and improved, next-generation perovskite solar cell November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||